NEWS


Phillips-Medisize boosts its global manufacturing capacity


Molex-owned company Phillips-Medis- ize, which specialises in drug delivery, diagnostic and medical technology devices, is to expand its manufacturing footprint and its capabilities in product design and development. Once this is all complete, the company will have 280,000 m2


of


manufacturing and R&D space in 36 facilities worldwide, plus 55,000 m2


of


Class 7 and 8 cleanrooms to support tool building sites and quality and regulatory systems. About 1,000 more employees will be taken on as a result. “Our expanded global reach and


resources will enable us to solve complex development and manufac- turing challenges while meeting escalating customer demands for more localised production, supply chain management and accelerated go-to- market strategies,” said Paul Chaffin, president of Molex’s Medical &


Smart material choice


Swedish compounder Polykemi has developed a simulation tool that allows it to provide cradle-to-grave carbon footprint data to custom- ers for any of its materials. This follows a scientific study by Polykemi in 2020 focused on analys- ing the climate impacts of the company’s materials. The study demonstrated that the choice of material has a significant part to play in the fight against climate change. � www.polykemi.com


4


Phillips-Medisize launched the Aria smart autoinjector earlier this year


Pharmaceutical Solutions business. To address growing demand in


Europe, Phillips-Medisize is building a medical manufacturing facility in Katowice, Poland. It is also expanding production capacity in Suzhou, China, for the global and regional pharmaceu- tical and medical technology markets.


IMAGE: PHILLIPS-MEDISIZE In the US, expansion at an existing


Molex facility at Little Rock, Arkansas, is already under way for high-volume, diagnostic devices. The company had completed a 26,000 m2


facility at St


Croix Meadows, Wisconsin, last year for the production of high-volume moulded components for medical diagnostics. This includes a 6,000 m2 Class 8 cleanroom.


Phillips-Medisize also announced a


strategic initiative with Credence MedSystems, including ramping production of the Credence Compan- ion and Dual Chamber Reconstitution Systems at its site in Letterkenny, Ireland, and the new facility in Poland. This follows other recent agreements with GlucoModicum and with Eyeven- sys on its ocular device component for the delivery of novel gene therapies for eye diseases. � www.molex.com


Pöppelmann grows in the US


Pöppelmann Plastic USA, the US subsidiary of the German injection moulder, will invest more than $19.2m to expand its manufacturing campus in Claremont, North Carolina. This will create 133 new jobs, including machine operators, maintenance technicians, warehouse personnel and administrative staff, according to State


Governor Roy Cooper. The site itself first opened in 2007 with a focus on plastic pots and cultivation systems for the commercial horticulture industry, but has since diversified. The expansion will add about 9,000 m2


to the automotive produc-


tion line. � www.poeppelmann.com


GHO invests in Sanner Group


Specialised healthcare investor Global Healthcare Opportunities has acquired Germany’s Sanner Group, which makes plastic packaging and components for the pharmaceutical, medical technology, diagnostics, healthcare products and nutritional


INJECTION WORLD | November/December 2021


supplements sectors. The amount involved was not disclosed. “We have been observ-


ing increasing consolidation in the market for some time now. As a medium-sized company, we must react if we want to remain success- ful in the long term,” said


shareholder Jürgen Sanner, from the founding family, which will remain involved. Following 15% year-on-


year growth in 2020, Sanner now makes over 4bn component parts/year and has over 600 employees. � www.ghocapital.com � www.sanner-group.com


www.injectionworld.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52